The utility of universal urinary drug screening in chronic pain management

References

• Simons SH , Anand KJ. Pain control: opioid dosing, population kinetics and side-effects. Semin Fetal Neonatal Med. 2006;11(4):260–267. doi:10.1016/j.siny.2006.02.008.
   Google Scholar
• Benyamin R , Trescot AM , Datta S , Buenaventura R , Adlaka R , Sehgal N , Glaser SE , Vallejo R . Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105–S120.
   Google Scholar
• Bohnert AS , Valenstein M , Bair MJ , Ganoczy D , McCarthy JF , Ilgen MA , Blow FC . Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–1321. doi:10.1001/jama.2011.370.
   Google Scholar
• Geller AS . Opioid overdose-related deaths. JAMA. 2011;306(4):379; author reply 380–381. doi:10.1001/jama.2011.1036.
   Google Scholar
• Noble M , Treadwell JR , Tregear SJ , Coates VH , Wiffen PJ , Akafomo C , Schoelles KM . Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1):CD006605. doi:10.1002/14651858.CD006605.pub2.
   Google Scholar
• Vowles KE , McEntee ML , Julnes PS , Frohe T , Ney JP , van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–576. doi:10.1097/01.j.pain.0000460357.01998.f1.
   Google Scholar
• Lynch ME , Katz J . “One size fits all” doesn’t fit when it comes to long-term opioid use for people with chronic pain. Clin J Pain. 2017;1(1):2–7. doi:10.1080/24740527.2017.1319733.
   Google Scholar
• Solanki DR , Koyyalagunta D , Shah RV , Silverman SM , Manchikanti L . Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician. 2011;14(2):E119–E131.
   Google Scholar
• Heit HA , Gourlay DL . Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260–267. doi:10.1016/j.jpainsymman.2003.07.008.
   Google Scholar
• Heit HA , Gourlay DL . Using urine drug testing to support healthy boundaries in clinical care. J Opioid Manag. 2015;11(1):7–12. doi:10.5055/jom.2015.0247.
   Google Scholar
• Owen GT , Burton AW , Schade CM , Passik S . Urine drug testing: current recommendations and best practices. Pain Physician. 2012;15(3 Suppl):ES119–ES133.
   Google Scholar
• Busse JW , Craigie S , Juurlink DN , Buckley DN , Wang L , Couban RJ , Agoritsas T , Akl EA , Carrasco-Labra A , Cooper L , et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–E666. doi:10.1503/cmaj.170363.
   Google Scholar
• Dupouy J , Memier V , Catala H , Lavit M , Oustric S , Lapeyre-Mestre M . Does urine drug abuse screening help for managing patients? A systematic review. Drug Alcohol Depend. 2014;136:11–20. doi:10.1016/j.drugalcdep.2013.12.009.
   Google Scholar
• Eichhorst JC , Etter ML , Rousseaux N , Lehotay DC . Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem. 2009;42(15):1531–1542. doi:10.1016/j.clinbiochem.2009.07.019.
   Google Scholar
• Saitman A , Park HD , Fitzgerald RL . False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38(7):387–396. doi:10.1093/jat/bku075.
   Google Scholar
• Tenore PL . Advanced urine toxicology testing. J Addict Dis. 2010;29(4):436–448. doi:10.1080/10550887.2010.509277.
   Google Scholar
• Moeller KE , Lee KC , Kissack JC . Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66–76. doi:10.4065/83.1.66.
   Google Scholar
• d’Entremont MA , Lynch ME , Clark AJ . Urinary drug screening in the management of pain: is it helpful in management? Poster presented at: Dalhousie Pain Research Day; 2014 May 9; Halifax, Nova Scotia, Canada.
   Google Scholar
• Lee CT , Vo TT , Cohen AS , Ahmed S , Zhang Y , Mao J , Chen L . Profiles of urine drug test in clinical pain patients vs pain research study subjects. Pain Med. 2016;17(4):636–643. doi:10.1111/pme.12900.
   Google Scholar
• Michna E , Jamison RN , Pham LD , Ross EL , Janfaza D , Nedeljkovic SS , Narang S , Palombi D , Wasan AD . Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23(2):173–179. doi:10.1097/AJP.0b013e31802b4f95.
   Google Scholar
• Manchikanti L , Manchukonda R , Pampati V , Damron KS . Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician. 2005;8(3):257–261.
   Google Scholar
• Manchikanti L , Damron KS , McManus CD , Barnhill RC . Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study. Pain Physician. 2004;7(4):431–437.
   Google Scholar
• Turner JA , Saunders K , Shortreed SM , Rapp SE , Thielke S , LeResche L , Riddell KM , Von Korff M . Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results. J Gen Intern Med. 2014;29(2):305–311. doi:10.1007/s11606-013-2651-6.
   Google Scholar
• Manchikanti L , Pampati V , Damron KS , Beyer CD , Barnhill RC . Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician. 2003;6(2):173–178.
   Google Scholar
• Fishbain DA , Cutler RB , Rosomoff HL , Rosomoff RS . Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15(3):184–191. doi:10.1097/00002508-199909000-00005.
   Google Scholar
• Berndt S , Maier C , Schutz HW . Polymedication and medication compliance in patients with chronic non-malignant pain. Pain. 1993;52(3):331–339. doi:10.1016/0304-3959(93)90167-N.
   Google Scholar
• Hariharan J , Lamb GC , Neuner JM . Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med. 2007;22(4):485–490. doi:10.1007/s11606-006-0084-1.
   Google Scholar
• Ives TJ , Chelminski PR , Hammett-Stabler CA , Malone RM , Perhac JS , Potisek NM , Shilliday BB , DeWalt DA , Pignone MP . Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46. doi:10.1186/1472-6963-6-46.
   Google Scholar
• West R , Pesce A , West C , Crews B , Mikel C , Rosenthal M , Almazan P , Latyshev S . Observations of medication compliance by measurement of urinary drug concentrations in a pain management population. J Opioid Manag. 2010;6(4):253–257. doi:10.5055/jom.2010.0023.
   Google Scholar
• Turner JA , Saunders K , Shortreed SM , LeResche L , Riddell K , Rapp SE , Von Korff M . Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results. J Gen Intern Med. 2014;29(12):1663–1671. doi:10.1007/s11606-014-3010-y.
   Google Scholar
• Pesce A , West C , Rosenthal M , Mikel C , West R , Crews B , Almazan P , Latyshev S , Horn PS . Illicit drug use in the pain patient population decreases with continued drug testing. Pain Physician. 2011;14(2):189–193.
   Google Scholar
• Smith HS . Opioid metabolism. Mayo Clin Proc. 2009;84(7):613–624. doi:10.1016/S0025-6196(11)60750-7.
   Google Scholar
• Thomas DR . A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–246. doi:10.1177/1098214005283748.
   Google Scholar
• Mirakbari SM , Innes GD , Christenson J , Tilley J , Wong H . Do co-intoxicants increase adverse event rates in the first 24 hours in patients resuscitated from acute opioid overdose? J Toxicol Clin Toxicol. 2003;41(7):947–953. doi:10.1081/CLT-120026516.
   Google Scholar
• Nova Scotia College of Pharmacists . Summary of federal and provincial laws and regulations governing the dispensing of prescription drugs in Nova Scotia. Halifax (Canada): Nova Scotia College of Pharmacists; 2015 [accessed 2017 May 30]. http://www.nspharmacists.ca/wp-content/uploads/2015/07/PrescriptionRegulationsChartCombined_Jun2015.pdf.
   Google Scholar
• Sleath B , Rubin RH , Campbell W , Gwyther L , Clark T . Physician–patient communication about over-the-counter medications. Soc Sci Med. 2001;53(3):357–369. doi:10.1016/S0277-9536(00)00341-5.
   Google Scholar
• Manchikanti L , Manchukonda R , Damron KS , Brandon D , McManus CD , Cash K . Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9(1):57–60.
   Google Scholar
• Manchikanti L , Manchukonda R , Pampati V , Damron KS , Brandon DE , Cash KA , McManus CD . Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician. 2006;9(2):123–129.
   Google Scholar
• Kirsh KL , Jass C , Bennett DS , Hagen JE , Passik SD . Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care. 2007;5(3):219–226. doi:10.1017/S1478951507000387.
   Google Scholar
• Leeuw M , Goossens ME , Linton SJ , Crombez G , Boersma K , Vlaeyen JW . The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30(1):77–94. doi:10.1007/s10865-006-9085-0.
   Google Scholar
• Province of Nova Scotia . Canadian addiction survey: Nova Scotia report. Prevalence of alcohol and illicit drug use and related harms in Nova Scotia. Halifax (Canada): Department of Health Promotion and Protection, Addiction Services; 2007 [accessed 2017 Nov 22]. https://novascotia.ca/dhw/addictions/documents/Canadian-Addiction-Survey-2007.pdf.
   Google Scholar